On-demand Global IP Spotlight briefing on Latin America covering AI, SEPs, pharmaceuticals, patent prosecution and oppositions, with takeaways for U.S. stakeholders.

Brazil's 2025 SEP litigation experienced significant growth, with Rio courts becoming a key forum, marked by procedural innovations, FRAND emphasis, and emerging connected-car disputes.

Fulbright Medical’s Shanghai Stock Exchange IPO was terminated after extensive Johnson & Johnson patent litigation, including multiple infringement suits and rising damages claims.

Brazil's Ministry of Health issued a new methodology for valuing technology transfer in PDPs, establishing pricing benchmarks and reimbursement rules for IP.

Brazil’s Health Ministry consolidates PDP technology-transfer pricing criteria, detailing F/BDI components, benchmarks, reimbursement logic, and governance steps.

Program listing for APLI Day 1 Panel 7 on injunctive relief, covering a global perspective for enforcing patents and building portfolios.

Silimed secured a Munich PI against Polytech over EP2581193, halting polyurethane-coated implant manufacture and sales in Germany amid parallel UPC action.

São Paulo Court of Justice reinstated an injunction in a med-tech patent dispute, granting suspensive effect to J&J’s extraordinary appeals against Scitech.

São Paulo court restored a temporary injunction in Johnson & Johnson v Scitech, reimposing Brazil’s ban on sales of Altus electric staplers.

David Medical and its subsidiary face Silag/Johnson & Johnson patent suits in China, with claimed damages raised to RMB 161.26 million.

BRPTO’s 2026 patent landscape maps satellite energy and space propulsion trends, showing Brazil’s growing filings and the dominance of research institutions.

Silimed becomes the first Brazilian UPC claimant, suing Polytech in Hamburg over EP’193 implant technology and seeking pan‑European injunctive relief.

Silimed becomes the first Brazilian claimant at the UPC, suing Polytech in Hamburg over EP2581193 and building on German entitlement wins.

The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.